Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Income from Continuing Operations (2022 - 2026)

Cannabis Bioscience International Holdings filings provide 5 years of Income from Continuing Operations readings, the most recent being 104035.0 for Q1 2026.

  • On a quarterly basis, Income from Continuing Operations rose 31.42% to 104035.0 in Q1 2026 year-over-year; TTM through Feb 2026 was 532943.0, a 76.64% decrease, with the full-year FY2025 number at 557627.0, down 12.17% from a year prior.
  • Income from Continuing Operations reached 104035.0 in Q1 2026 per CBIH's latest filing, down from 99107.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 18270.0 in Q2 2024, with the low at 324655.0 in Q1 2023.
  • A 5-year average of 152913.5 and a median of 127871.0 in 2025 define the central range for Income from Continuing Operations.
  • Year-over-year, Income from Continuing Operations soared 106.62% in 2024 and then crashed 1400.76% in 2025.
  • Year by year, Income from Continuing Operations stood at 219886.0 in 2022, then skyrocketed by 57.02% to 94512.0 in 2023, then increased by 27.7% to 68328.0 in 2024, then tumbled by 45.05% to 99107.0 in 2025, then fell by 4.97% to 104035.0 in 2026.
  • Per Business Quant, the three most recent readings for CBIH's Income from Continuing Operations are 104035.0 (Q1 2026), 99107.0 (Q4 2025), and 92152.0 (Q3 2025).